| First Author | Kasahara K | Year | 2010 |
| Journal | Blood | Volume | 115 |
| Issue | 6 | Pages | 1277-9 |
| PubMed ID | 19996413 | Mgi Jnum | J:157777 |
| Mgi Id | MGI:4436960 | Doi | 10.1182/blood-2009-06-227645 |
| Citation | Kasahara K, et al. (2010) Impaired clot retraction in factor XIII A subunit-deficient mice. Blood 115(6):1277-9 |
| abstractText | Factor XIII (FXIII) is a plasma transglutaminase that cross-links fibrin monomers, alpha(2)-plasmin inhibitor, and so forth. Congenital FXIII deficiency causes lifelong bleeding symptoms. To understand the molecular pathology of FXIII deficiency in vivo, its knockout mice have been functionally analyzed. Because prolonged bleeding times, a sign of defective/abnormal primary hemostasis, were commonly observed in 2 separate lines of FXIII A subunit (FXIII-A) knockout mice, a possible role or roles of FXIII in platelet-related function was investigated in the present study. Although platelet aggregation induced by adenosine diphosphate or collagen was normal, clot retraction (CR) was lost in the platelet-rich plasma (PRP) of FXIII-A knockout mice. In contrast, there was no CR impairment in the PRP of tissue transglutaminase-knockout mice compared with that of wild-type mice. Furthermore, a transglutaminase inhibitor, cystamine, halted CR in the PRP of wild-type mice. These results indicate that the enzymatic activity of FXIII is necessary for CR, at least in mice. |
